Cargando…
Agreement of amyloid PET and CSF biomarkers for Alzheimer's disease on Lumipulse
OBJECTIVE: To determine the cutoffs that optimized the agreement between (18)F‐Florbetapir positron emission tomography (PET) and Aβ1‐42, Aβ1‐40, tTau, pTau and their ratios measured in cerebrospinal fluid (CSF) on the LUMIPULSE G600II instrument, we quantified the levels of these four biomarkers in...
Autores principales: | , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6764494/ https://www.ncbi.nlm.nih.gov/pubmed/31464088 http://dx.doi.org/10.1002/acn3.50873 |